122 related articles for article (PubMed ID: 31160300)
1. Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma.
Spalato Ceruso M; Napolitano A; Silletta M; Vincenzi B
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31160300
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases.
Fleming GF; Heimann PS; Stephens JK; Simon MA; Ferguson MK; Benjamin RS; Samuels BL
Cancer; 1993 Aug; 72(3):714-8. PubMed ID: 8334623
[TBL] [Abstract][Full Text] [Related]
3. An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.
Gagliato Dde M; Linck RD; Bezerra RO; Souto M; Lopes GL; Baiocchi G; Mano MS
J Med Case Rep; 2016 Mar; 10():60. PubMed ID: 26971567
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
Hof H; Welzel T; Debus J
Onkologie; 2006 Dec; 29(12):572-4. PubMed ID: 17202828
[TBL] [Abstract][Full Text] [Related]
5. [The chordoma. Description of 2 clinical cases and results of oncolytic chemotherapy].
Mensi F; Bombara R; Massari A; Sala F; Visca U
Minerva Med; 1979 Sep; 70(40):2759-66. PubMed ID: 481800
[TBL] [Abstract][Full Text] [Related]
6. Chordoma: a case series and review of the literature.
Alan O; Akin Telli T; Ercelep O; Tanrikulu Simsek E; Basoglu Tuylu T; Mutis A; Hasanov R; Kaya S; Akgül Babacan N; Dane F; Yumuk PF
J Med Case Rep; 2018 Aug; 12(1):239. PubMed ID: 30145982
[TBL] [Abstract][Full Text] [Related]
7. Response to imatinib plus sirolimus in advanced chordoma.
Stacchiotti S; Marrari A; Tamborini E; Palassini E; Virdis E; Messina A; Crippa F; Morosi C; Gronchi A; Pilotti S; Casali PG
Ann Oncol; 2009 Nov; 20(11):1886-94. PubMed ID: 19570961
[TBL] [Abstract][Full Text] [Related]
8. Giant Recurrent Sacral Chordoma.
Jing L; Wang G
World Neurosurg; 2019 Feb; 122():96-97. PubMed ID: 30391769
[TBL] [Abstract][Full Text] [Related]
9. Metronomic cyclophosphamide with cisplatin and bevacizumab: a new chemotherapeutic regimen for refractory anaplastic ependymoma.
Lorgis V; Varbedian O; Ghiringhelli F
Anticancer Res; 2012 Nov; 32(11):5067-70. PubMed ID: 23155280
[TBL] [Abstract][Full Text] [Related]
10. [Chordoma cutis, an unusual clinical presentation of a rare neoplasm: Chordoma].
Delteil C; Malissen N; Appay R; Magis Q; Aubert S; Bouvier C; Richard MA; Macagno N
Ann Pathol; 2018 Apr; 38(2):126-130. PubMed ID: 29449046
[TBL] [Abstract][Full Text] [Related]
11. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Wildiers H; Tryfonidis K; Dal Lago L; Vuylsteke P; Curigliano G; Waters S; Brouwers B; Altintas S; Touati N; Cardoso F; Brain E
Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
[TBL] [Abstract][Full Text] [Related]
12. Image-guided percutaneous lipiodol-pingyangmycin suspension injection therapy for sacral chordoma.
Huang D; Chen Y; Zeng Q; Wu R; Li Y
Korean J Radiol; 2013; 14(5):823-8. PubMed ID: 24043980
[TBL] [Abstract][Full Text] [Related]
13. Oral metronomic chemotherapy for recurrent & refractory epithelial ovarian cancer: A retrospective analysis.
Sharma A; Malik PS; Khurana S; Kumar S; Bhatla N; Ray MD; Kumar L
Indian J Med Res; 2019 Dec; 150(6):575-583. PubMed ID: 32048620
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
Devadas SK; Banavali S
Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
16. Long clinical benefit achieved in two patients with malignant paraganglioma treated by metronomic cyclophosphamide.
Gillon P; Godbert Y; Dupin C; Bubien V; Italiano A; Roubaud G
Future Oncol; 2014 Nov; 10(14):2121-5. PubMed ID: 25471026
[TBL] [Abstract][Full Text] [Related]
17. Durable complete response to chemotherapy in an infant with a clival chordoma.
Al-Rahawan MM; Siebert JD; Mitchell CS; Smith SD
Pediatr Blood Cancer; 2012 Aug; 59(2):323-5. PubMed ID: 21922644
[TBL] [Abstract][Full Text] [Related]
18. Cryosurgery in the excision of a giant local recurrent sacral chordoma: a case report and literature review.
Pipola V; Girolami M; Ghermandi R; Tedesco G; Evangelisti G; Gasbarrini A
Eur Spine J; 2018 Dec; 27(12):3059-3063. PubMed ID: 29372428
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography-guided percutaneous cryoablation for recurrent sacral chordoma following carbon ion radiotherapy: A case report.
Inaba N; Nakayama R; Mori T; Hosaka S; Susa M; Yabe H; Inoue M; Nakatsuka S; Nakamura M; Matsumoto M; Toyama Y; Morioka H
J Orthop Sci; 2019 Mar; 24(2):368-372. PubMed ID: 27839912
[No Abstract] [Full Text] [Related]
20. Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study.
Stacchiotti S; Morosi C; Lo Vullo S; Casale A; Palassini E; Frezza AM; Dinoi G; Messina A; Gronchi A; Cavalleri A; Venturelli E; Morelli D; Pilotti S; Collini P; Brich S; Tamborini E; Mariani L; Casali PG
Cancer; 2018 Oct; 124(20):4056-4063. PubMed ID: 30216418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
